Femto Technologies Inc. has announced a private placement offering that will generate approximately $17 million in gross proceeds. The company will issue common shares and warrants to institutional investors at $4.17 per common unit, with the transaction expected to close on February 27, 2025.
The offering includes common shares, Series A warrants with an initial exercise price of $5.21, and Series B warrants with an initial exercise price of $12.51. These securities will provide the company with additional financial resources to advance its FemTech initiatives, particularly the development of Sensera, its innovative feminine wellness device.
Femto plans to use the net proceeds for general corporate purposes and working capital. The company, which recently received a CES Innovation Awards® 2025 Honorary mention in the AI category, is leveraging its proprietary Smart Release System (SRS) technology to create adaptive wellness solutions.
The private placement represents a strategic financial move for Femto Technologies, enabling continued investment in research and development of its AI-powered feminine wellness technologies. By securing this funding, the company aims to further its mission of bridging gaps in women's health and wellness through innovative technological solutions.
